Skip to content
healthcare.dev

Abilify Asimtufii

NDC 59148-102, Aripiprazole, injection, suspension, extended release, from Otsuka America Pharmaceutical, Inc.

Product NDC
59148-102
Status
Listed
Labeler
Otsuka America Pharmaceutical, Inc
Dosage form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217006
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59148-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ARIPIPRAZOLE720 mg/2.4mL

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
59148-102-80591480102801 SYRINGE in 1 CARTON (59148-102-80) / 2.4 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/da4c07fd-1130-4341-bb44-63acfa4162be
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=59148-102
  • NADAC price for package 59148010280

    GET /v1/drugs/nadac/59148010280

Use it

Look up 59148-102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59148-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59148-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.